{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:52:21Z","timestamp":1793425941839,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd004143.pub6","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000}}],"reference-count":383,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004143.pub7","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T10:24:23Z","timestamp":1788517463000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Long-term hormone therapy for perimenopausal and postmenopausal women"],"prefix":"10.1002","volume":"2026","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1979-183X","authenticated-orcid":false,"given":"Magdalena","family":"Bofill Rodriguez","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynaecology and Reproductive Sciences; University of Auckland; Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li Ning","family":"Yong","sequence":"additional","affiliation":[{"name":"Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanja","family":"Mirkov","sequence":"additional","affiliation":[{"name":"Pharmacy Department; Cairns and Hinterland Hospital and Health Service; Cairns, Queensland 4870 Australia"},{"name":"School of Pharmacy and Pharmaceutical Sciences; The University of Queensland; Woolloongabba, Queensland 4102 Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Bekos","sequence":"additional","affiliation":[{"name":"Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Lethaby","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynaecology and Reproductive Sciences; University of Auckland; Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Farquhar","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynaecology and Reproductive Sciences; University of Auckland; Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"key":"10.1002\/14651858.CD004143.pub7-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1200\/JCO.2005.02.8464","article-title":"Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group study","volume":"24","author":"Barakat","year":"2006","journal-title":"Journal of Clinical Oncology"},{"issue":"7","key":"10.1002\/14651858.CD004143.pub7-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1212\/WNL.0000000000002980","article-title":"Cognitive effects of estradiol after menopause - a randomized trial of the timing hypothesis","volume":"87","author":"Henderson","year":"2016","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD004143.pub7-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/GME.0000000000000343","article-title":"Methods and baseline cardiovascular data from the Early versus Late Intervention Trial with Estradiol testing the menopausal timing hypothesis","volume":"22","author":"Hodis","year":"2015","journal-title":"Menopause (New York, N.Y.)"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0004|cit4","article-title":"Testing the menopausal hormone therapy timing hypothesis: the Early versus Late Intervention Trial with Estradiol","volume":"130","author":"Hodis","year":"2014","journal-title":"Circulation"},{"issue":"13","key":"10.1002\/14651858.CD004143.pub7-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1056\/NEJMoa1505241","article-title":"Vascular effects of early versus late postmenopausal treatment with estradiol","volume":"374","author":"Hodis","year":"2016","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"10.1002\/14651858.CD004143.pub7-BIB0006|cit6","first-page":"1330","article-title":"Cognitive outcomes from the early versus late intervention trial with estradiol: a test of the critical window hypothesis","volume":"21","author":"Mack","year":"2014","journal-title":"Menopause (New York, N.Y.)"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"939","DOI":"10.7326\/0003-4819-135-11-200112040-00005","article-title":"Estrogen in the prevention of atherosclerosis: a randomized, double-blind, placebo-controlled trial","volume":"135","author":"Hodis","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD004143.pub7-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1097\/01.GME.0000153934.76086.A4","article-title":"Determinants of the effect of estrogen on the progression of subclinical atherosclerosis: Estrogen in the Prevention of Atheroscerosis Trial","volume":"12","author":"Karim","year":"2005","journal-title":"Menopause (New York, N.Y.)"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1472-6874-8-5","article-title":"Symptom reporting and quality of life in the Estonian Postmenopausal Hormone Therapy Trial","volume":"8","author":"Veerus","year":"2010","journal-title":"BMC Women's Health"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.maturitas.2006.01.012","article-title":"Results from the Estonian postmenopausal hormone therapy trial (IRSRCTN35338757)","volume":"55","author":"Veerus","year":"2006","journal-title":"Maturitas"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.maturitas.2005.05.001","article-title":"Treatment adherence in the Estonian postmenopausal hormone therapy (EPHT) trial (ISRCTN35339757)","volume":"52","author":"Vorobjov","year":"2005","journal-title":"Maturitas"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1056\/NEJM200008243430801","article-title":"Effects of oestrogen replacement on the progression of coronary artery atherosclerosis","volume":"343","author":"Herrington","year":"2000","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/s0197-2456(00)00054-4","article-title":"The estrogen replacement and atherosclerosis (ERA) study: study design and baseline characteristics of the cohort","volume":"21","author":"Herrington","year":"2000","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1080\/13697130008500132","article-title":"The ERA trial: findings and implications for the future","volume":"3","author":"Nair","year":"2000","journal-title":"Climacteric"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/1471-0528.12598","article-title":"Long-term safety of unopposed estrogen used by women surviving myocardial infarction: 14-year follow-up of the ESPRIT randomised controlled trial","volume":"121","author":"Cherry","year":"2014","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1016\/s0140-6736(02)12001-0","article-title":"Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial","volume":"360","author":"The Esprit Team","year":"2002","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1046\/j.1365-2141.2001.03111.x","article-title":"Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double-blind, placebo-controlled trial","volume":"115","author":"Hoibraaten","year":"2001","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1055\/s-0037-1615717","article-title":"The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism - Results from a randomized, double-blind, clinical trial","volume":"85","author":"Hoibraaten","year":"2001","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1055\/s-0037-1614156","article-title":"Increased risk of recurrent venous thromboembolism during hormone replacement therapy","volume":"84","author":"Hoibraaten","year":"2000","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1080\/cmt.5.1.26.35","article-title":"Endometrial safety and bleeding patterns during a 2-year study of 1 or 2 mg 17 beta-estradiol combined with sequential 5-20 mg dydrogesterone","volume":"5","author":"Ferenczy","year":"2002","journal-title":"Climacteric"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.amjmed.2005.03.004","article-title":"The effect of hormone replacement on physical performance in community-dwelling elderly women","volume":"118","author":"Greenspan","year":"2005","journal-title":"American Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD004143.pub7-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.amjcard.2004.09.021","article-title":"Effect of hormone therapy among women with heart failure and coronary artery disease","volume":"95","author":"Bibbins-Domingo","year":"2005","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1161\/01.ATV.0000033514.79653.04","article-title":"Effect of oestrogen plus progestin on progression of carotid atherosclerosis in postmenopausal women with heart disease","volume":"22","author":"Byington","year":"2002","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/s0197-2456(98)00010-5","article-title":"Heart and Estrogen\/progestin Replacement Study (HERS): design, methods and baseline characteristics","volume":"19","author":"Grady","year":"1998","journal-title":"Controlled Clinical Trials"},{"issue":"1","key":"10.1002\/14651858.CD004143.pub7-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1001\/jama.288.1.49","article-title":"Cardiovascular disease outcomes during 6.8 years of hormone therapy","volume":"288","author":"Grady","year":"2002","journal-title":"Journal of the American Medical Association"},{"issue":"9","key":"10.1002\/14651858.CD004143.pub7-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"689","DOI":"10.7326\/0003-4819-132-9-200005020-00002","article-title":"Postmenopausal hormone therapy increases risk for venous thromboembolic disease","volume":"132","author":"Grady","year":"2000","journal-title":"Annals of Internal Medicine"},{"issue":"7","key":"10.1002\/14651858.CD004143.pub7-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/s0002-9343(02)01270-6","article-title":"Effect of postmenopausal hormone therapy on cognitive function: the Heart and Estrogen\/progestin Replacement Study","volume":"113","author":"Grady","year":"2002","journal-title":"Americal Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD004143.pub7-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/s0002-8703(98)70191-7","article-title":"Comparison of the Heart and Oestrogen Replacement Study (HERS) cohort with women with coronary disease from the National Health and Nutrition Examination Survey III (NHANES III)","volume":"136","author":"Herrington","year":"1998","journal-title":"American Heart Journal"},{"issue":"25","key":"10.1002\/14651858.CD004143.pub7-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1161\/01.cir.0000019406.74017.b2","article-title":"Statin therapy, cardiovascular events and total mortality in the Heart and Estrogen\/progestin Replacement Study (HERS)","volume":"105","author":"Herrington","year":"2002","journal-title":"Circulation"},{"issue":"11","key":"10.1002\/14651858.CD004143.pub7-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1097\/GME.0000000000001230","article-title":"Hot flushes, coronary heart disease, and hormone therapy in postmenopausal women","volume":"25","author":"Huang","year":"2018","journal-title":"Menopause (New York, N.Y.)"},{"issue":"1","key":"10.1002\/14651858.CD004143.pub7-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1001\/jama.288.1.58","article-title":"Noncardiovascular disease outcomes during 6.8 years of hormone therapy","volume":"288","author":"Hulley","year":"2002","journal-title":"Journal of the American Medical Association"},{"issue":"7","key":"10.1002\/14651858.CD004143.pub7-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/s0002-9149(03)00121-8","article-title":"Effect of postmenopausal hormone therapy on coronary heart disease events after percutaneous transluminal coronary angioplasty","volume":"91","author":"Khan","year":"2003","journal-title":"American Journal of Cardiology"},{"issue":"5","key":"10.1002\/14651858.CD004143.pub7-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1161\/01.cir.103.5.638","article-title":"Postmenopausal hormone therapy and risk of stroke: the Heart and Estrogen-progestin Replacement Study (HERS)","volume":"103","author":"Simon","year":"2001","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"493","DOI":"10.7326\/0003-4819-135-7-200110020-00008","article-title":"Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease","volume":"135","author":"Simon","year":"2001","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0036|cit36","doi-asserted-by":"crossref","unstructured":"Vandenbroucke JP Hormone replacement therapy for secondary prevention of coronary heart disease JAMA 1999 281 9 794 7 10-1001\/pubs.JAMA-ISSN-0098-7484-281-9-jbk0303","DOI":"10.1001\/jama.281.9.794"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"81","DOI":"10.7326\/0003-4819-138-2-200301210-00007","article-title":"Risk factors and secondary prevention in women with heart disease: the Heart and Estrogen\/progestin Replacement Study","volume":"138","author":"Vittinghoff","year":"2003","journal-title":"Annals of Internal Medicine"},{"key":"#cr-split#-10.1002\/14651858.CD004143.pub7-BIB0038|cit38.1","unstructured":"Asthana S Gleason CE Wharton W Dowling MN Carlsson CM The Kronos Early Estrogen Prevention Study: results of the cognitive and affective substudy (KEEPS-Cog) Menopause: 23rd Annual Meeting of North American Menopause Society, 2012 October 3-6"},{"key":"#cr-split#-10.1002\/14651858.CD004143.pub7-BIB0038|cit38.2","unstructured":"Orlando (FL) 2012 1365 404 10.1097\/gme.0b013e3182739e2f"},{"issue":"10","key":"10.1002\/14651858.CD004143.pub7-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1089\/jwh.2014.4871","article-title":"Effects of different hormone therapies on breast pain in recently postmenopausal women: findings from the Mayo Clinic KEEPS Breast Pain Ancillary Study","volume":"23","author":"FIles","year":"2014","journal-title":"Journal of Womens Health"},{"key":"#cr-split#-10.1002\/14651858.CD004143.pub7-BIB0040|cit40.1","unstructured":"Gleason C Wharton W Dowling M Brinton E Santoro N The Kronos Early Estrogen Prevention Study - Cognitive and Affective Sub-study (KEEPS-CA): menopausal hormone therapy effects on mood, quality of life and memory complaints Menopause: 23rd Annual Meeting of North American Menopause Society, 2012 Oct 3-6"},{"key":"#cr-split#-10.1002\/14651858.CD004143.pub7-BIB0040|cit40.2","unstructured":"Orlando (FL) 2012 1402 (P 89) 10.1097\/gme.0b013e3182739e2f"},{"issue":"6","key":"10.1002\/14651858.CD004143.pub7-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"e1001833","DOI":"10.1371\/journal.pmed.1001833","article-title":"Effects of hormone therapy on cognition and mood in recently postmenopausal women: findings from the randomized, controlled KEEPS-cognitive and affective study","volume":"12","author":"Gleason","year":"2015","journal-title":"PLoS Medicine"},{"issue":"6","key":"10.1002\/14651858.CD004143.pub7-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"e1001833","DOI":"10.1371\/journal.pmed.1001833","article-title":"Effects of hormone therapy on cognition and mood in recently postmenopausal women: findings from the randomized controlled KEEPS-Cognitive and Affective Study","volume":"12","author":"Gleason","year":"2015","journal-title":"PLoS Medicine"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"249","DOI":"10.7326\/M14-0353","article-title":"Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women","volume":"161","author":"Harman","year":"2014","journal-title":"Annals of Internal Medicine"},{"key":"#cr-split#-10.1002\/14651858.CD004143.pub7-BIB0044|cit44.1","unstructured":"Harman SM Effects of oral conjugated estrogen or transdermal estradiol plus oral progesterone treatment on common carotid artery intima media thickness (CIMT) & coronary artery calcium (CAC) in menopausal women: initial results from the Kronos Early Estrogen Prevention Study (KEEPS) Menopause: 23rd Annual Meeting of North American Menopause Society, 2012 Oct 3-6"},{"key":"#cr-split#-10.1002\/14651858.CD004143.pub7-BIB0044|cit44.2","unstructured":"Orlando (FL) 2012 1365 404 10.1097\/gme.0b013e3182739e2f"},{"issue":"9","key":"10.1002\/14651858.CD004143.pub7-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1212\/WNL.0000000000002970","article-title":"Effects of hormone therapy on brain structure in recently postmenopausal women: a randomized controlled trial","volume":"87","author":"Kantarci","year":"2016","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0046|cit46","doi-asserted-by":"crossref","unstructured":"Kantarci K Tosakulwong N Lesnick TG Zuk SM Lowe VJ Brain structure and cognition 3 years after the end of an early menopausal hormone therapy trial Neurology 2018 90 1 e1404 e1412 10.1212\/WNL.0000000000005325","DOI":"10.1212\/WNL.0000000000005325"},{"issue":"16","key":"10.1002\/14651858.CD004143.pub7-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"e1404","DOI":"10.1212\/WNL.0000000000005325","article-title":"Brain structure and cognition 3 years after the end of an early menopausal hormone therapy trial","volume":"90","author":"Kantarci","year":"2018","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD004143.pub7-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3109\/13697137.2014.986719","article-title":"Endothelial function in women of the Kronos Early Estrogen Prevention Study","volume":"18","author":"Kling","year":"2015","journal-title":"Climacteric"},{"key":"#cr-split#-10.1002\/14651858.CD004143.pub7-BIB0049|cit49.1","unstructured":"The KRONOS Early Prevention Study (KEEPS): rationale, design and baseline characteristics of the study population Menopause: 23rd Annual Meeting of North American Menopause Society, 2012 Oct 3-6"},{"key":"#cr-split#-10.1002\/14651858.CD004143.pub7-BIB0049|cit49.2","unstructured":"Orlando (FL) 2012 1365 404 10.1097\/gme.0b013e3182739e2f"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0050|cit50","unstructured":"Kronos Early Estrogen Prevention Study (KEEPS) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00154180"},{"key":"#cr-split#-10.1002\/14651858.CD004143.pub7-BIB0051|cit51.1","unstructured":"Naftolin F Harman SM Black D Brinton E Budoff M Adverse events during four years of daily oral conjugated estrogen or transdermal estradiol plus cyclic oral progesterone treatment in recently menopausal women: the KRONOS Early Estrogen Prevention Study (KEEPS) Menopause: 23rd Annual Meeting of North American Menopause Society, 2012 Oct 3-6"},{"key":"#cr-split#-10.1002\/14651858.CD004143.pub7-BIB0051|cit51.2","unstructured":"Orlando (FL) 2012 1402 3 (P-90) 10.1097\/gme.0b013e3182739e2f"},{"issue":"3","key":"10.1002\/14651858.CD004143.pub7-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3109\/13697137.2015.1116504","article-title":"Effects of menopausal hormone therapy on serum serotonin and self-report depression in healthy, recently menopausal women","volume":"22","author":"Raz","year":"2013","journal-title":"Journal of Women's Health"},{"key":"#cr-split#-10.1002\/14651858.CD004143.pub7-BIB0053|cit53.1","unstructured":"Rexrode KM Manson JE Kalan K Lobo R Freeman R Effects of oral conjugated estrogen or transdermal estradiol plus oral progesterone treatment on breast outcomes among menopausal women in the Kronos Early Estrogen Prevention Study (KEEPS) Menopause: 23rd Annual Meeting of North American Menopause Society, 2012 Oct 3-6"},{"key":"#cr-split#-10.1002\/14651858.CD004143.pub7-BIB0053|cit53.2","unstructured":"Orlando (FL) 2012 1403 (P 92) 10.1097\/gme.0b013e3182739e2f"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3233\/JAD-130245","article-title":"The KEEPS - Cognitive and Affective Study: baseline associations between vascular risk factors and cognition","volume":"2","author":"Wharton","year":"2014","journal-title":"Journal of Alzheimer's Disease"},{"issue":"8","key":"10.1002\/14651858.CD004143.pub7-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1001\/jama.283.8.1007","article-title":"Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial","volume":"283","author":"Mulnard","year":"2000","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD004143.pub7-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1097\/00006250-197907000-00017","article-title":"Estrogen replacement therapy II: a prospective study in the relationship to carcinoma and cardiovascular and metabolic problems","volume":"54","author":"Nachtigall","year":"1979","journal-title":"Obstetrics and Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD004143.pub7-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/00042192-200209000-00007","article-title":"Effectiveness of Alora estradiol matrix transdermal delivery system in improving lumbar bone mineral density in health, postmenopausal women","volume":"9","author":"Notelovitz","year":"2002","journal-title":"Menopause (New York, N.Y.)"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1159\/000012289","article-title":"Combined versus sequential hormonal replacement therapy: a double blind placebo-controlled study on quality of life-related measures","volume":"67","author":"Bech","year":"1998","journal-title":"Psychotherapy and Psychosomatics"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0059|cit59","unstructured":"Bech P Personal communication with J. Marjoribanks."},{"key":"10.1002\/14651858.CD004143.pub7-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0378-5122(93)90129-6","article-title":"A two-year double-blind controlled study of the clinical effect of combined and sequential postmenopausal replacement therapy and steroid metabolism during treatment","volume":"16","author":"Obel","year":"1993","journal-title":"Maturitas"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0378-5122(97)00041-8","article-title":"The postmenopausal estrogen\/progestin interventions study: primary outcomes in adherent women","volume":"27","author":"Barrett-Connor","year":"1997","journal-title":"Maturitas"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/01.CIR.100.7.717","article-title":"Effect of postmenopausal hormones on inflammation-sensitive proteins","volume":"100","author":"Cushman","year":"1999","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/0197-2456(94)00033-Y","article-title":"Rationale, design and conduct of the PEPI trial","volume":"16","author":"Espeland","year":"1995","journal-title":"Controlled Clinical Trials"},{"issue":"1","key":"10.1002\/14651858.CD004143.pub7-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/jnci\/95.1.30","article-title":"Postmenopausal hormone therapy and change in mammographic density","volume":"951","author":"Greendale","year":"2003","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"54S","DOI":"10.1016\/0197-2456(94)00113-H","article-title":"Baseline characteristics of the PEPI particpants","volume":"16","author":"Miller","year":"1995","journal-title":"Controlled Clinical Trials"},{"issue":"3","key":"10.1002\/14651858.CD004143.pub7-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3109\/13697139809085538","article-title":"Effect of hormone replacement therapy on self-reported cognitive symptoms: results from the Postmenopausal Estrogen\/Progestin Interventions (PEPI) trial","volume":"13","author":"Reboussin","year":"1998","journal-title":"Climacteric"},{"issue":"3","key":"10.1002\/14651858.CD004143.pub7-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.1995.03520270033028","article-title":"Effects of estrogen or estrogen\/progestin regimens on heart disease risk factors in postmenopausal women","volume":"273","author":"Writing Group for the PEPI Trial","year":"1995","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD004143.pub7-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/jama.1996.03530290040035","article-title":"Effects of hormone replacement therapy on endometrial histology in postmenopausal women","volume":"275","author":"Writing Group for the PEPI Trial","year":"1996","journal-title":"JAMA"},{"issue":"4","key":"10.1002\/14651858.CD004143.pub7-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1080\/13697137.2017.1325459","article-title":"Prevention of postmenopausal osteoporosis in Chinese women: a 5-year, double-blind, randomized, parallel placebo-controlled study","volume":"20","author":"Ran","year":"2017","journal-title":"Climateric"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.maturitas.2017.03.248","article-title":"Prevention of postmenopausal osteoporosis in Chinese women: a 5-year double-blind, randomized, parallel placebo control study","volume":"100","year":"2017","journal-title":"Maturitas"},{"issue":"5","key":"10.1002\/14651858.CD004143.pub7-BIB0071|cit71","doi-asserted-by":"publisher","first-page":"133S","DOI":"10.1097\/01.AOG.0000514678.75674.b8","article-title":"Replenish trial: combination capsule of estradiol\/progesterone (TX-001HR) for treating hot flushes","volume":"129","author":"Archer","year":"2017","journal-title":"Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD004143.pub7-BIB0072|cit72","article-title":"Replenish trial: endometrial safety with a 173-estradiol and progesterone combination (TX-001HR) in postmenopausal women with vasomotor symptoms","volume":"38","author":"Archer","year":"2017","journal-title":"Endocrine Reviews"},{"issue":"12","key":"10.1002\/14651858.CD004143.pub7-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1097\/GME.0000000000001615","article-title":"17beta-estradiol\/progesterone in a single, oral, softgel capsule (TX-001HR) significantly increased the number of symptom-free days in the replenish trial","volume":"27","author":"Kaunitz","year":"2020","journal-title":"Menopause (New York, N.Y.)"},{"issue":"12","key":"10.1002\/14651858.CD004143.pub7-BIB0074|cit74","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1097\/GME.0000000000001631","article-title":"Breast effects of oral, combined 17\u03b2-estradiol, and progesterone capsules in menopausal women: a randomized controlled trial","volume":"27","author":"Liu","year":"2020","journal-title":"Menopause (New York, N.Y.)"},{"issue":"1","key":"10.1002\/14651858.CD004143.pub7-BIB0075|cit75","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.cardfail.2019.09.006","article-title":"Menopausal hormone therapy and risks of first hospitalized heart failure and its subtypes during the intervention and extended postintervention follow-up of the Women's Health Initiative randomized trials","volume":"26","author":"Liu","year":"2020","journal-title":"Journal of Cardiac Failure"},{"issue":"1","key":"10.1002\/14651858.CD004143.pub7-BIB0076|cit76","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/AOG.0000000000002645","article-title":"A 17beta-estradiol-progesterone oral capsule for vasomotor symptoms in postmenopausal women: a randomized controlled trial","volume":"132","author":"Lobo","year":"2018","journal-title":"Menopause (New York, N.Y.)"},{"issue":"6","key":"10.1002\/14651858.CD004143.pub7-BIB0077|cit77","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1080\/13697137.2019.1640197","article-title":"Metabolic and cardiovascular effects of TX-001HR in menopausal women with vasomotor symptoms","volume":"22","author":"Lobo","year":"2019","journal-title":"Climacteric"},{"issue":"12","key":"10.1002\/14651858.CD004143.pub7-BIB0078|cit78","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1097\/GME.0000000000001251","article-title":"Effects of single-capsule 17\u03b2-estradiol\/progesterone (TX-001HR) on metabolic parameters and cardiovascular outcomes in menopausal women of the replenish trial","volume":"25","author":"Liu","year":"2018","journal-title":"Menopause (New York, N.Y.)"},{"issue":"1","key":"10.1002\/14651858.CD004143.pub7-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.maturitas.2015.02.266","article-title":"17-Estradiol and natural progesterone for menopausal hormone therapy: REPLENISH phase 3 study design of a combination capsule and evidence review","volume":"81","author":"Mirkin","year":"2015","journal-title":"Maturitas"},{"issue":"4","key":"10.1002\/14651858.CD004143.pub7-BIB0080|cit80","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1097\/GME.0000000000001480","article-title":"Endometrial safety and bleeding profile of a 17\u03b2-estradiol\/progesterone oral softgel capsule (TX-001HR)","volume":"27","author":"Mirkin","year":"2020","journal-title":"Menopause (New York, N.Y.)"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0081|cit81","unstructured":"A safety and efficacy study of the combination estradiol and progesterone to treat vasomotor symptoms (REPLENISH) https:\/\/clinicaltrials.gov\/study\/NCT01942668"},{"issue":"7","key":"10.1002\/14651858.CD004143.pub7-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.psyneuen.2009.02.009","article-title":"A randomized double-blind trial of the effects of hormone therapy on delayed verbal recall in older women","volume":"34","author":"Tierney","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ahj.2004.01.025","article-title":"Remnant-like lipoproteins, hormone therapy and angiographic and clinical outcomes: the Women's Angiographic Vitamin and Estrogen trial","volume":"147","author":"Bittner","year":"2004","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0197-2456(02)00237-4","article-title":"Women's angiographic vitamin and estrogen trial: design and methods","volume":"23","author":"Hsia","year":"2002","journal-title":"Controlled Clinical Trials"},{"issue":"19","key":"10.1002\/14651858.CD004143.pub7-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.288.19.2432","article-title":"Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women","volume":"288","author":"Waters","year":"2002","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD004143.pub7-BIB0086|cit86","first-page":"85","article-title":"Estrogen after ischemic stroke: clinical basis and design of the Women's Estrogen for Stroke Trial","volume":"7","author":"Kernan","year":"1998","journal-title":"Journal of Stroke and Cardiovascular Diseases"},{"issue":"17","key":"10.1002\/14651858.CD004143.pub7-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1056\/NEJMoa010534","article-title":"A clinical trial of estrogen-replacement therapy after ischemic stroke","volume":"345","author":"Viscoli","year":"2001","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ajog.2004.08.017","article-title":"Estrogen therapy and risk of cognitive decline: results from the Women's Estrogen for Stroke Trial (WEST)","volume":"192","author":"Viscoli","year":"2004","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S1470-2045(12)70075-X","article-title":"Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial","volume":"13","author":"Anderson","year":"2012","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.maturitas.2006.05.004","article-title":"Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin","volume":"55","author":"Anderson","year":"2006","journal-title":"Maturitas"},{"issue":"13","key":"10.1002\/14651858.CD004143.pub7-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1001\/jama.290.13.1739","article-title":"Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures","volume":"290","author":"Anderson","year":"2003","journal-title":"Journal of the American Medical Association"},{"issue":"3","key":"10.1002\/14651858.CD004143.pub7-BIB0092|cit92","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/gerona\/glz208","article-title":"Associations of hearing loss and menopausal hormone therapy with change in global cognition and incident cognitive impairment among postmenopausal women","volume":"75","author":"Armstrong","year":"2020","journal-title":"Journals of Gerontology"},{"issue":"5 Part 1","key":"10.1002\/14651858.CD004143.pub7-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/01.AOG.0000158120.47542.18","article-title":"Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative","volume":"105","author":"Barnabei","year":"2005","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1001\/archinte.165.17.1976","article-title":"Effects of conjugated equine estrogen on health-related quality of life in postmenopausal women with hysterectomy","volume":"165","author":"Brunner","year":"2005","journal-title":"Archives of Internal Medicine"},{"issue":"13","key":"10.1002\/14651858.CD004143.pub7-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.290.13.1729","article-title":"Effects of estrogen plus progestin on risk of fracture and bone mineral density","volume":"290","author":"Cauley","year":"2003","journal-title":"Journal of the American Medical Association"},{"issue":"2","key":"10.1002\/14651858.CD004143.pub7-BIB0096|cit96","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.ygyno.2010.02.018","article-title":"Estrogen alone and lung cancer in postmenopausal women","volume":"117","author":"Chlebowski","year":"2010","journal-title":"Gynecologic Oncology"},{"issue":"15","key":"10.1002\/14651858.CD004143.pub7-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/jama.2010.1500","article-title":"Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women","volume":"304","author":"Chlebowski","year":"2010","journal-title":"JAMA"},{"issue":"4 Suppl","key":"10.1002\/14651858.CD004143.pub7-BIB0098|cit98","doi-asserted-by":"publisher","first-page":"GS5","DOI":"10.1158\/1538-7445.SABCS19-GS5-00","article-title":"Long-term influence of estrogen plus progestin and estrogen alone use on breast cancer incidence: the Women's Health Initiative randomized trials","volume":"80","author":"Chlebowski","year":"2020","journal-title":"Cancer Research"},{"issue":"4","key":"10.1002\/14651858.CD004143.pub7-BIB0099|cit99","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1001\/jama.2020.9482","article-title":"Association of menopausal hormone therapy with breast cancer incidence and mortality during long-term follow-up of the women's health initiative randomized clinical trials","volume":"324","author":"Chlebowski","year":"2020","journal-title":"JAMA"},{"issue":"12","key":"10.1002\/14651858.CD004143.pub7-BIB0100|cit100","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1097\/01.ogx.0000723348.06789.02","article-title":"Association of menopausal hormone therapy with breast cancer incidence and mortality during long-term follow-up of the Women's Health Initiative randomized clinical trials","volume":"75","author":"Chlebowski","year":"2020","journal-title":"Obstetrical & Gynecological Survey"},{"issue":"4","key":"10.1002\/14651858.CD004143.pub7-BIB0101|cit101","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1001\/jama.2020.9482","article-title":"Association of menopausal hormone therapy with breast cancer incidence and mortality during long-term follow-up of the Women\u2019s Health Initiative randomized clinical trials","volume":"324","author":"Chlebowski","year":"2020","journal-title":"Journal American Medical Association"},{"issue":"18","key":"10.1002\/14651858.CD004143.pub7-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/jnci\/djq285","article-title":"Lung cancer among postmenopausal women treated with estrogen alone in the Women's Health Initiative randomized trial","volume":"102","author":"Chlebowski","year":"2010","journal-title":"Journal of the National Cancer Institute"},{"issue":"3","key":"10.1002\/14651858.CD004143.pub7-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/djv350","article-title":"Continuous combined estrogen plus progestin and endometrial cancer","volume":"108","author":"Chlebowski","year":"2016","journal-title":"Journal of the National Cancer Institute"},{"issue":"2","key":"10.1002\/14651858.CD004143.pub7-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/2042098614568300","article-title":"Menopausal hormone therapy and breast cancer mortality: clinical implications","volume":"6","author":"Chlebowski","year":"2015","journal-title":"Therapeutic Advances in Drug Safety"},{"issue":"7","key":"10.1002\/14651858.CD004143.pub7-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"917","DOI":"10.6004\/jnccn.2015.0106","article-title":"Menopausal hormone therapy influence on breast cancer outcomes in the Women's Health Initiative","volume":"13","author":"Chlebowski","year":"2015","journal-title":"Journal of the National Comprehensive Cancer Network"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0106|cit106","doi-asserted-by":"crossref","unstructured":"Chlebowski RT Barrington W Aragaki AK Manson JE Sarto G O'Sullivan MJ Estrogen alone and health outcomes in black women by African ancestry Journal of Clinical Oncology. Conference: 2015 Annual Meeting of the American Society of Clinical Oncology, ASCO Chicago (IL) 2015","DOI":"10.1200\/jco.2015.33.15_suppl.1502"},{"issue":"6","key":"10.1002\/14651858.CD004143.pub7-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/GME.0b013e31828392c4","article-title":"Estrogen alone and joint symptoms in the Women's Health Initiative randomized trial","volume":"20","author":"Chlebowski","year":"2013","journal-title":"Menopause (New York, N.Y.)"},{"issue":"24","key":"10.1002\/14651858.CD004143.pub7-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1001\/jama.289.24.3243","article-title":"Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women","volume":"289","author":"Chlebowski","year":"2003","journal-title":"JAMA"},{"issue":"360","key":"10.1002\/14651858.CD004143.pub7-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1056\/NEJMoa0807684","article-title":"Breast cancer after use of estrogen plus progestin in postmenopausal women","volume":"6","author":"Chlebowski","year":"2009","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0110|cit110","first-page":"3","article-title":"Breast cancer after use of estrogen plus progestin in postmenopausal women","volume":"57","author":"Chlebowski","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD004143.pub7-BIB0111|cit111","first-page":"296","article-title":"Breast cancer after use of estrogen plus progestin and estrogen alone","volume":"1","author":"Chlebowski","year":"2015","journal-title":"JAMA"},{"issue":"9697","key":"10.1002\/14651858.CD004143.pub7-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0140-6736(09)61526-9","article-title":"Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial","volume":"374","author":"Chlebowski","year":"2009","journal-title":"Lancet"},{"issue":"10","key":"10.1002\/14651858.CD004143.pub7-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa032071","article-title":"Estrogen plus progestin and colorectal cancer in postmenopausal women","volume":"350","author":"Chlebowski","year":"2004","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD004143.pub7-BIB0114|cit114","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cllc.2015.09.004","article-title":"Estrogen plus progestin and lung cancer: follow-up of the Women's Health Initiative randomized trial","volume":"17","author":"Chlebowski","year":"2016","journal-title":"Clinical Lung Cancer"},{"issue":"3","key":"10.1002\/14651858.CD004143.pub7-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/jama.293.3.330","article-title":"Effect of estrogen therapy on gallbladder disease","volume":"293","author":"Cirillo","year":"2005","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/archinte.166.7.772","article-title":"Venous thrombosis and conjugated equine estrogen in women without a uterus","volume":"166","author":"Curb","year":"2006","journal-title":"Archives of Internal Medicine"},{"issue":"13","key":"10.1002\/14651858.CD004143.pub7-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1001\/jama.292.13.1573","article-title":"Estrogen plus progestin and risk of venous thrombosis","volume":"292","author":"Cushman","year":"2004","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.2337\/dc15-1385","article-title":"Impact of type 2 diabetes and postmenopausal hormone therapy on incidence of cognitive impairment in older women","volume":"38","author":"Espeland","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1212\/WNL.0000000000001816","article-title":"Postmenopausal hormone therapy, type 2 diabetes mellitus, and brain volumes","volume":"85","author":"Espeland","year":"2015","journal-title":"Neurology"},{"issue":"7","key":"10.1002\/14651858.CD004143.pub7-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1532-5415.2010.02953.x","article-title":"Long-term effects of conjugated equine estrogen therapies on domain-specific cognitive function: results from the Women's Health Initiative study of cognitive aging extension","volume":"58","author":"Espeland","year":"2010","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0121|cit121","doi-asserted-by":"crossref","unstructured":"Espeland MA Rapp SR Manson JA Goveas JS Shumaker SA Hayden KM Long term effects on cognitive trajectories of early versus late postmenopausal hormone therapy Alzheimer's & Dementia: The Journal of the Alzheimer's Association 2016 12 7 195 6 10.1016\/j.jalz.2016.06.340","DOI":"10.1016\/j.jalz.2016.06.340"},{"issue":"6","key":"10.1002\/14651858.CD004143.pub7-BIB0122|cit122","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1093\/gerona\/glw156","article-title":"Long-term effects on cognitive trajectories of postmenopausal hormone therapy in two age groups","volume":"72","author":"Espeland","year":"2017","journal-title":"Journal of Gerontology"},{"issue":"6","key":"10.1002\/14651858.CD004143.pub7-BIB0123|cit123","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1093\/gerona\/glw156","article-title":"Long-term effects on cognitive trajectories of postmenopausal hormone therapy in two age groups","volume":"72","author":"Espeland","year":"2016","journal-title":"Journals of Gerontology Series A-Biological Sciences and Medical Sciences"},{"issue":"24","key":"10.1002\/14651858.CD004143.pub7-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1001\/jama.291.24.2959","article-title":"Conjugated equine estrogens and global cognitive function in postmenopausal women","volume":"291","author":"Espeland","year":"2004","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S1047-2797(03)00042-5","article-title":"The Women's Health Initiative recruitment methods and results","volume":"13","author":"Hays","year":"2003","journal-title":"Annals of Epidemiology"},{"issue":"19","key":"10.1002\/14651858.CD004143.pub7-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJMoa030311","article-title":"Effects of estrogen plus progestin on health-related quality of life","volume":"348","author":"Hays","year":"2003","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD004143.pub7-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1001\/jama.299.9.1036","article-title":"Health risks and benefit 3 years after stopping randomized treatment with estrogen and progestin","volume":"299","author":"Heiss","year":"2008","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1161\/CIRCULATIONAHA.105.594077","article-title":"Effects of conjugated equine estrogen on stroke in the Women's Health Initiative","volume":"113","author":"Hendrix","year":"2006","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1001\/archinte.166.3.357","article-title":"Conjugated equine estrogens and coronary heart disease","volume":"166","author":"Hsia","year":"2006","journal-title":"Archives of Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD004143.pub7-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1359\/jbmr.060312","article-title":"Effects of conjugated equine estrogen on risk of fractures and BMD in postmenopausal women with hysterectomy: results from the Women's Health Initiative randomized trial","volume":"21","author":"Jackson","year":"2006","journal-title":"Journal of Bone and Mineral Research"},{"issue":"13","key":"10.1002\/14651858.CD004143.pub7-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1001\/jama.2011.382","article-title":"Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy","volume":"305","author":"LaCroix","year":"2011","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1002\/cncr.29464","article-title":"Estrogen and colorectal cancer incidence and mortality","volume":"121","author":"Lavasani","year":"2015","journal-title":"Cancer"},{"issue":"1","key":"10.1002\/14651858.CD004143.pub7-BIB0133|cit133","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.cardfail.2019.09.006","article-title":"Menopausal hormone therapy and risks of first hospitalized heart failure and its subtypes during the intervention and extended postintervention follow-up of the women's health initiative randomized trials","volume":"26","author":"Liu","year":"2020","journal-title":"Journal Cardiac Failure"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004143.pub7-BIB0134|cit134","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/jbmr.4206","article-title":"Hormone therapy reduces the risk of fracture regardless of baseline FRAX probability or prior falls - Results from the Women's Health Initiative hormone therapy trials","volume":"35","author":"Lorentzon","year":"2020","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0135|cit135","unstructured":"Lorentzon M Johansson H Harvey NC Liu E Crandall J McCloskey EV Hormone therapy reduces the risk of fracture in fallers and in non-fallers: results from the Women's Health Initiative hormone therapy trials Osteoporosis International 2019 30 Suppl 2 S163 10.1007\/s00198-019-04990-z"},{"issue":"4","key":"10.1002\/14651858.CD004143.pub7-BIB0136|cit136","first-page":"359","article-title":"Hormone therapy decreases the risk of fracture both in fallers and nonfallers. Data from the combined Women's Health Initiative hormone therapy trials","volume":"3","year":"2019","journal-title":"Journal of Bone and Mineral Research"},{"issue":"6","key":"10.1002\/14651858.CD004143.pub7-BIB0137|cit137","doi-asserted-by":"publisher","first-page":"406","DOI":"10.7326\/M19-0274","article-title":"Menopausal estrogen-alone therapy and health outcomes in women with and without bilateral oophorectomy","volume":"171","author":"Manson","year":"2019","journal-title":"Annals of Internal Medicine"},{"issue":"10","key":"10.1002\/14651858.CD004143.pub7-BIB0138|cit138","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1001\/jama.2017.11217","article-title":"Menopausal hormone therapy and long-term all-cause and cause-specific mortality: the Women's Health Initiative randomized trials","volume":"318","author":"Manson","year":"2017","journal-title":"JAMA"},{"issue":"10","key":"10.1002\/14651858.CD004143.pub7-BIB0139|cit139","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1001\/jama.2017.11217","article-title":"Menopausal hormone therapy and long-term all-cause and cause-specific mortality: the Women\u2019s Health Initiative randomized trials","volume":"318","author":"Manson","year":"2017","journal-title":"JAMA"},{"issue":"13","key":"10.1002\/14651858.CD004143.pub7-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.2013.278040","article-title":"Menopausal hormone therapy and health outcomes during the intervention and extended post-stopping phases of the Women's Health Initiative randomized trials","volume":"310","author":"Manson","year":"2013","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa030808","article-title":"Estrogen plus progestin and the risk of coronary heart disease","volume":"349","author":"Manson","year":"2003","journal-title":"New England Medical Journal"},{"issue":"2","key":"10.1002\/14651858.CD004143.pub7-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1037\/0003-066X.52.2.101","article-title":"Women's Health Initiative: why now? What is it? What's new?","volume":"52","author":"Matthews","year":"1997","journal-title":"American Psychologist"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0143|cit143","unstructured":"National Institutes of Health NIH News: NIH asks participants in Women's Health Initiative estrogen-alone study to stop study pills, begin follow-up phase National Institutes of Health Website: www.nih.gov\/news"},{"issue":"5","key":"10.1002\/14651858.CD004143.pub7-BIB0144|cit144","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1002\/jbmr.3070","article-title":"Dietary inflammatory index, bone mineral density, and risk of fracture in postmenopausal women: results from the Women's Health Initiative","volume":"32","author":"Orchard","year":"2017","journal-title":"Journal of Bone and Mineral Research"},{"issue":"12","key":"10.1002\/14651858.CD004143.pub7-BIB0145|cit145","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1097\/GME.0000000000000997","article-title":"The relationship between migraine, cardiovascular disease (CVD) and hormone therapy (HT) in postmenopausal women in the Women's Health Initiative study (WHI)","volume":"24","author":"Pavlovic","year":"2017","journal-title":"Menopause (New York, N.Y.)"},{"issue":"11","key":"10.1002\/14651858.CD004143.pub7-BIB0146|cit146","doi-asserted-by":"publisher","first-page":"e006887","DOI":"10.1161\/JAHA.117.006887","article-title":"Coronary artery calcification (CAC) and post-trial cardiovascular events and mortality within the Women's Health Initiative (WHI) estrogen-alone trial","volume":"6","author":"Poornima","year":"2017","journal-title":"Journal of the American Heart Association"},{"issue":"12","key":"10.1002\/14651858.CD004143.pub7-BIB0147|cit147","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1093\/aje\/kwn090","article-title":"Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study","volume":"167","author":"Prentice","year":"2008","journal-title":"American Journal of Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD004143.pub7-BIB0148|cit148","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1093\/aje\/kwn090","article-title":"Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study","volume":"167","author":"Prentice","year":"2008","journal-title":"American Journal of Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD004143.pub7-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1158\/1055-9965.EPI-08-1209","article-title":"Colorectal cancer in relation to postmenopausal estrogen and estrogen plus progestin in the Women's Health Initiative clinical trial and observational study","volume":"18","author":"Prentice","year":"2009","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"issue":"20","key":"10.1002\/14651858.CD004143.pub7-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1001\/jama.289.20.2663","article-title":"Effect of estrogen plus progestin on global cognitive function in postmenopausal women","volume":"289","author":"Rapp","year":"2003","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1191\/1740774504cn040oa","article-title":"The Women's Health Initiative Study of Cognitive Aging (WHISCA): a randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline","volume":"1","author":"Resnick","year":"2004","journal-title":"Clinical Trials (London, England)"},{"issue":"11","key":"10.1002\/14651858.CD004143.pub7-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1210\/jc.2009-1340","article-title":"Effects of conjugated equine oestrogens on cognition and affect in postmenopausal women with prior hysterectomy","volume":"94","author":"Resnick","year":"2009","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1210\/jc.2005-2097","article-title":"Effects of combination estrogen plus progestin hormone treatment on cognition and affect","volume":"91","author":"Resnick","year":"2006","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"10","key":"10.1002\/14651858.CD004143.pub7-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1158\/1055-9965.EPI-08-0385","article-title":"Conjugated equine estrogens and colorectal cancer incidence and survival: the Women's Health Initiative randomized clinical trial","volume":"17","author":"Ritenbaugh","year":"2008","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"issue":"13","key":"10.1002\/14651858.CD004143.pub7-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jama.297.13.1465","article-title":"Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause","volume":"297","author":"Rossouw","year":"2007","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0156|cit156","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1097\/JTO.0000000000000558","article-title":"Hormone use, reproductive history, and risk of lung cancer: the Women's Health Initiative studies","volume":"10","author":"Schwartz","year":"2015","journal-title":"Journal of Thoracic Oncology"},{"issue":"1370","key":"10.1002\/14651858.CD004143.pub7-BIB0157|cit157","doi-asserted-by":"publisher","first-page":"s4","DOI":"10.1097\/GME.0000000000000783","article-title":"Estrogen-alone therapy and invasive breast cancer incidence by dose, formulation, and route of delivery: findings from the WHI observational study","volume":"23","author":"Shufelt","year":"2016","journal-title":"Menopause (New York, N.Y.)"},{"issue":"24","key":"10.1002\/14651858.CD004143.pub7-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.291.24.2947","article-title":"Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study","volume":"291","author":"Shumaker","year":"2004","journal-title":"JAMA"},{"issue":"20","key":"10.1002\/14651858.CD004143.pub7-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1001\/jama.289.20.2651","article-title":"Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women","volume":"289","author":"Shumaker","year":"2003","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S0197-2456(98)00038-5","article-title":"The Women's Health Initiative Memory Study (WHIMS): a trial of the effect of estrogen therapy in preventing and slowing the progression of dementia","volume":"19","author":"Shumaker","year":"1998","journal-title":"Controlled Clinical Trials"},{"issue":"32","key":"10.1002\/14651858.CD004143.pub7-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1200\/JCO.2012.42.7732","article-title":"Estrogen plus progestin and colorectal cancer incidence and mortality","volume":"30","author":"Simon","year":"2012","journal-title":"Journal of Clinical Oncology"},{"issue":"14","key":"10.1002\/14651858.CD004143.pub7-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1001\/jama.295.14.1647","article-title":"Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy","volume":"295","author":"Stefanick","year":"2006","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/S1047-2797(03)00045-0","article-title":"The Women's Health Initiative postmenopausal hormone trials: overview and baseline characteristics of participants","volume":"13","author":"Stefanick","year":"2003","journal-title":"Annals of Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD004143.pub7-BIB0164|cit164","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/GME.0000000000000775","article-title":"Age of menopause and fracture risk in postmenopausal women randomized to calcium + vitamin D, hormone therapy, or the combination: results from the Women's Health Initiative Clinical Trials","volume":"24","author":"Sullivan","year":"2017","journal-title":"Menopause (New York, N.Y.)"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1093\/jnci\/djr333","article-title":"Menopausal hormone therapy and risks of melanoma and non melanoma skin cancers: Women\u2019s Health Initiative randomized trials","volume":"103","author":"Tang","year":"2011","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0197-2456(97)00078-0","article-title":"Design of the Women's Health Initiative clinical trial and observational study","volume":"19","author":"The Women's Health Initiative Study Group","year":"1998","journal-title":"Controlled Clinical Trials"},{"issue":"4","key":"10.1002\/14651858.CD004143.pub7-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"211","DOI":"10.7326\/0003-4819-152-4-201002160-00005","article-title":"Coronary heart disease in postmenopausal recipients of estrogen plus progestin therapy: does the increased risk ever disappear? A randomized trial","volume":"152","author":"Toh","year":"2010","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.brainres.2013.03.047","article-title":"The rationale, design, and baseline characteristics of the Women's Health Initiative Memory Study of Younger Women (WHIMS-Y)","volume":"1514","author":"Vaughan","year":"2013","journal-title":"Brain Research"},{"issue":"3","key":"10.1002\/14651858.CD004143.pub7-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/art.23325","article-title":"Effects of postmenopausal hormone therapy on rheumatoid arthritis: the Women's Health Initiative randomized controlled trials","volume":"59","author":"Walitt","year":"2008","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1055\/s-0034-1384627","article-title":"Stroke findings in the Women's Health Initiative","volume":"32","author":"Wassertheil-Smoller","year":"2014","journal-title":"Seminars in Reproductive Medicine"},{"issue":"20","key":"10.1002\/14651858.CD004143.pub7-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1001\/jama.289.20.2673","article-title":"Effect of estrogen plus progestin on stroke in postmenopausal women","volume":"289","author":"Wassertheil-Smoller","year":"2003","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD004143.pub7-BIB0172|cit172","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1210\/jc.2016-3270","article-title":"No increase in fractures after stopping hormone therapy: results from the Women's Health Initiative","volume":"102","year":"2017","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"14","key":"10.1002\/14651858.CD004143.pub7-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial","volume":"291","author":"Women's Health Initiative Steering Committee","year":"2004","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/ebm.7.5.137","article-title":"Oestrogen plus progestogen increased coronary heart disease and breast cancer events in postmenopausal women","volume":"7","author":"Writing Group for the Women's Health Initiative investigators","year":"2002","journal-title":"British Medical Journal Evidence-Based Medicine"},{"issue":"3","key":"10.1002\/14651858.CD004143.pub7-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Writing Group for the Women's Health Initiative investigators","year":"2002","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/bcr3632","article-title":"Sex hormone associations with breast cancer risk and the mediation of randomized trial postmenopausal hormone therapy effects","volume":"16","author":"Zhao","year":"2014","journal-title":"Breast Cancer Research"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0177|cit177","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1136\/bmj.39266.425069.AD","article-title":"Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women","volume":"335","author":"Vickers","year":"2007","journal-title":"British Medical Journal Online First"},{"issue":"2","key":"10.1002\/14651858.CD004143.pub7-BIB0178|cit178","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6874-7-2","article-title":"The women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial","volume":"7","author":"Vickers","year":"2007","journal-title":"BMC Women's Health"},{"issue":"212","key":"10.1002\/14651858.CD004143.pub7-BIB0179|cit179","doi-asserted-by":"publisher","first-page":"a1190","DOI":"10.1136\/bmj.a1190","article-title":"Health related quality of life after combined hormone replacement therapy: randomised controlled trial","volume":"337","author":"Welton","year":"2008","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0180|cit180","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1001\/archneur.63.7.945","article-title":"Effects of ultra-low-dose transdermal estradiol on cognition and health-related quality of life","volume":"63","author":"Yaffe","year":"2006","journal-title":"Archives of Neurology"},{"issue":"35","key":"10.1002\/14651858.CD004143.pub7-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1200\/JCO.2015.60.9719","article-title":"Adjuvant hormone therapy may improve survival in epithelial ovarian cancer: results of the AHT randomized trial","volume":"33","author":"Eeles","year":"2015","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1042\/cs0410597","article-title":"The effects of oophorectomy and long-term mestranol therapy therapy on the serum lipids of middle-aged women","volume":"41","author":"Aitken","year":"1971","journal-title":"Clinical Science"},{"issue":"5758","key":"10.1002\/14651858.CD004143.pub7-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1136\/bmj.2.5758.400-c","article-title":"Oestrogen in oophorectomized women","volume":"2","author":"Aitken","year":"1971","journal-title":"British Medical Journal"},{"issue":"7","key":"10.1002\/14651858.CD004143.pub7-BIB0184|cit184","first-page":"607","article-title":"Prevention of bone loss following oophorectomy in premenopausal women: a retrospective assessment of the effects of oophorectomy and a prospective controlled trial of the effects of mestranol therapy","volume":"12","author":"Aitken","year":"1976","journal-title":"Israel Journal of Medical Sciences"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0185|cit185","first-page":"18","article-title":"Long-term oestrogens for the prevention of post-menopausal osteoporosis","volume":"52 Suppl 6","author":"Aitken","year":"1976","journal-title":"Postgraduate Medical Journal"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0186|cit186","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1136\/bmj.3.5879.515","article-title":"Oestrogen replacement therapy for prevention of osteoporosis after oophorectomy","volume":"3","author":"Aitken","year":"1973","journal-title":"British Medical Journal"},{"issue":"7968","key":"10.1002\/14651858.CD004143.pub7-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/S0140-6736(76)92217-0","article-title":"Long-term prevention of postmenopausal osteoporosis by oestrogen","volume":"1","author":"Lindsay","year":"1976","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD004143.pub7-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1161\/01.ATV.21.2.262","article-title":"Effect of oral postmenopausal hormone replacement on progression of atherosclerosis: a randomised controlled trial","volume":"21","author":"Angerer","year":"2001","journal-title":"Arteriosclerosis, Thrombosis and Vascular Biology"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0189|cit189","first-page":"57","article-title":"Association between target organ responses during hormone replacement therapy","volume":"5 Suppl 1","author":"Bloch Thomsen","year":"2002","journal-title":"Abstracts of Posters:10th World Congresss on Menopause, Climacteric"},{"issue":"5","key":"10.1002\/14651858.CD004143.pub7-BIB0190|cit190","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00042192-200109000-00009","article-title":"Comparison of transdermal and oral estrogen-progestin replacement therapy: effects on cardiovascular risk factors","volume":"8","author":"Chen","year":"2001","journal-title":"Menopause: The Journal of the North American Menopause Society"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0191|cit191","first-page":"2230","article-title":"Effects of natural oestogen\/gestagen and thiazide on coronary risk factors in normal postmenopausal women: a 2 year double-blind placebo study","volume":"143","author":"Christiansen","year":"1981","journal-title":"Ugeskrift for Laeger"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0192|cit192","first-page":"173","article-title":"Effects of the phytoestrogen genistein and hormone replacement therapy on bone mineral density and metabolism in early post-menopausal women: a randomised double blind placebo-controlled study","volume":"5 (Suppl 1)","author":"Corrado","year":"2002","journal-title":"Abstracts of Posters: 10th World Congress on Menopause: Climacteric"},{"issue":"6","key":"10.1002\/14651858.CD004143.pub7-BIB0193|cit193","first-page":"279","article-title":"Effect of a unique constant-estrogen, pulsed-progestin hormone replacement therapy containing 17-Beta estradiol and norgestimate on endometrial histology","volume":"44","author":"Corson","year":"1999","journal-title":"International Journal of Fertility"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0194|cit194","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1161\/01.ATV.19.12.2993","article-title":"Both raloxifene and estrogen reduce major cardiovascular risk factors in healthy postmenopausal women: a 2-year placebo-controlled study","volume":"19","author":"De Valk-de Roo","year":"1999","journal-title":"Arteriosclerosis, Thrombosis and Vascular Biology"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1067\/mob.2002.122092","article-title":"Neither long-term treatment with raloxifene nor hormone replacement therapy modulate cardiac function in health postmenopausal women: two randomized, placebo-controlled, 2-year studies","volume":"186","author":"Vogelvang","year":"2002","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"P3: Poster Pres","key":"10.1002\/14651858.CD004143.pub7-BIB0196|cit196","first-page":"937","article-title":"The role of cardiovascular health in moderating the effects of postmenopausal hormone therapy on neuroimaging outcomes","volume":"13","author":"Dowling","year":"2017","journal-title":"Alzheimer's & Dementia: the Journal of the Alzheimer's Association"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0197|cit197","doi-asserted-by":"crossref","first-page":"191S","DOI":"10.1016\/S8756-3282(96)00266-9","article-title":"Effect of 10 years' hormone replacement therapy on bone mineral content in postmenopausal women","volume":"5 Suppl","author":"Eiken","year":"1996","journal-title":"Bone"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0198|cit198","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1001\/archinte.1997.00440430091011","article-title":"Low-dose esterified estrogen therapy","volume":"157","author":"Genant","year":"1997","journal-title":"Archives of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD004143.pub7-BIB0199|cit199","first-page":"130","article-title":"Low-dose unopposed estrogens: preliminary findings on the frequency and duration of vaginal bleeding in postmenopausal women receiving esterified estrogens over a two-year period","volume":"4","author":"Trabal","year":"1997","journal-title":"Menopause: The Journal of the North American Menopause Society"},{"issue":"6","key":"10.1002\/14651858.CD004143.pub7-BIB0200|cit200","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00042192-200011000-00002","article-title":"Esterified estrogen therapy in postmenopausal women. Relationships of bone marker changes and plasma estradiol to BMD changes: a two year study","volume":"7","author":"Watts","year":"2000","journal-title":"Menopause (New York, N.Y.)"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0201|cit201","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1046\/j.1365-2796.2000.00675.x","article-title":"The EWA (Estrogen in Women with Atheroscelerosis) Study: a randomized study of the use of hormone replacement therapy in women with angiographically verified coronary artery disease. Characteristics of the study population. Effects on lipids and lipoproteins","volume":"247","author":"Os","year":"2000","journal-title":"Journal of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD004143.pub7-BIB0202|cit202","first-page":"579","article-title":"Effect of estrone sulfate on postmenopausal bone loss","volume":"76","author":"Genant","year":"1990","journal-title":"Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD004143.pub7-BIB0203|cit203","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1001\/jamapsychiatry.2017.3998","article-title":"Efficacy of transdermal estradiol and micronized progesterone in the prevention of depressive symptoms in the menopause transition: A randomized clinical trial","volume":"75","author":"Gordon","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0204|cit204","first-page":"87","article-title":"Effects of a combination of 2 mg estradiol valerate and 3 mg dienogest on coagulation, lipid profile and glucose metabolism in postmenopausal women","volume":"37 Suppl","author":"Graser","year":"2001","journal-title":"Drugs of Today (Barcelona, Spain: 1998)"},{"issue":"9407","key":"10.1002\/14651858.CD004143.pub7-BIB0205|cit205","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(04)15493-7","article-title":"HABITS (hormonal replacement therapy after breast cancer - is it safe?) A randomised comparison: trial stopped","volume":"363","author":"Holmberg","year":"2004","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0206|cit206","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0378-5122(02)00340-7","article-title":"A prospective, randomized, placebo-controlled study of the dose effect of oral oestradiol on menopausal symptoms, psychological well being and quality of life in postmenopausal Chinsese women","volume":"44","author":"Haines","year":"2003","journal-title":"Maturitas"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0207|cit207","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0378-5122(97)00080-7","article-title":"Longterm effects of hormone replacement therapy on symptoms of angina pectoris, quality of life and compliance in women with coronary artery disease","volume":"28","author":"Hall","year":"1998","journal-title":"Maturitas"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0208|cit208","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM198510173131602","article-title":"Cigarette smoking, serum estrogens and bone loss during hormone-replacement therapy early after menopause","volume":"313","author":"Jensen","year":"1985","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0209|cit209","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0378-5122(98)00085-1","article-title":"HRT and vit D in prevention of non-vertebral fractures in postmenopausal women: a 5 year randomized trial","volume":"31","author":"Komulainen","year":"1998","journal-title":"Maturitas"},{"issue":"1","key":"10.1002\/14651858.CD004143.pub7-BIB0210|cit210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-117-1-1","article-title":"Treatment of postmenopausal osteoporosis with transdermal estrogen","volume":"117","author":"Lufkin","year":"1992","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0211|cit211","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0197-4580(04)80357-9","article-title":"Changes in self-reported personality coincident with declines in cognition: results from parallel hormone therapy trials in elderly men and women","volume":"25 Suppl 2","author":"Maki","year":"2004","journal-title":"Neurobiology of Aging"},{"issue":"5","key":"10.1002\/14651858.CD004143.pub7-BIB0212|cit212","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1089\/jwh.2015.5351","article-title":"Gynaecologic safety of conjugated estrogens plus bazedoxifene: pooled analysis of five phase 3 trials","volume":"25","author":"Mirkin","year":"2016","journal-title":"Journal of Women's Health"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0213|cit213","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3109\/13697130902926910","article-title":"Dose effects of oral estradiol on bone mineral density in Japanese women with osteoporosis","volume":"13","author":"Mizunuma","year":"2010","journal-title":"Climacteric"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0214|cit214","unstructured":"Effects of estrogen on memory in post-menopausal women and patients with Alzheimer disease https:\/\/clinicaltrials.gov\/study\/NCT00006399"},{"issue":"2","key":"10.1002\/14651858.CD004143.pub7-BIB0215|cit215","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1447-0756.1993.tb00360.x","article-title":"Estradiol administered in a percutaneous gel for the prevention of postmenopausal bone loss","volume":"19","author":"Ng","year":"1993","journal-title":"Asia-Oceania Journal of Obstetrics and Gynaecology"},{"issue":"2","key":"10.1002\/14651858.CD004143.pub7-BIB0216|cit216","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.maturitas.2005.04.003","article-title":"Pulsed estrogen therapy improves postmenopausal quality of life: a 2-year placebo-controlled study","volume":"53","author":"Nielsen","year":"2006","journal-title":"Maturitas"},{"issue":"2","key":"10.1002\/14651858.CD004143.pub7-BIB0217|cit217","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s00198-003-1535-8","article-title":"Pulsed estrogen therapy in prevention of postmenopausal osteoporosis. A 2-year randomized, double blind, placebo-controlled study","volume":"15","author":"Nielsen","year":"2004","journal-title":"Osteoporosis International"},{"issue":"8","key":"10.1002\/14651858.CD004143.pub7-BIB0218|cit218","doi-asserted-by":"publisher","first-page":"735","DOI":"10.4065\/73.8.735","article-title":"Effects of long-term transdermal administration of estradiol on serum lipids","volume":"73","author":"Ory","year":"1998","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0219|cit219","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000064667","article-title":"Hormone replacement therapy does not affect plasma homocysteine in postmenopausal women with coronary artery disease","volume":"98","author":"Os","year":"2002","journal-title":"Cardiology"},{"issue":"5","key":"10.1002\/14651858.CD004143.pub7-BIB0220|cit220","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3109\/09513590.2014.1003294","article-title":"Clinical effect of hormonal replacement therapy with estradiol associated with noretisterone or drosperinone. A prospective randomized placebo controlled study","volume":"31","author":"Paoletti","year":"2015","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0221|cit221","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/j.1471-0528.2002.01544.x","article-title":"A study of hormone-replacement therapy in postmenopausal women with ischaemic heart disease: the Papworth HRT atherosclerosis study","volume":"109","author":"Clarke","year":"2002","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"3","key":"10.1002\/14651858.CD004143.pub7-BIB0222|cit222","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1532-5415.2007.01085.x","article-title":"The effect of 3-year treatment with 0.25 mg\/day of micronized 17beta-estradiol on cognitive function in older postmenopausal women","volume":"55","author":"Pefanco","year":"2007","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0223|cit223","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1067\/mob.2001.117340","article-title":"Raloxifene reduces impedance to flow within the uterine artery in early postmenopausal women: a 2-year randomized placebo-controlled comparative study","volume":"185","author":"Post","year":"2001","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0224|cit224","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1067\/mob.2002.122092","article-title":"Neither long-term treatment with raloxifene nor hormone replacement therapy modulate cardiac function in healthy postmenopausal women: two randomized, placebo-controlled, 2-year studies","volume":"186","author":"Vogelvang","year":"2002","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD004143.pub7-BIB0225|cit225","doi-asserted-by":"crossref","first-page":"e89095","DOI":"10.1371\/journal.pone.0089095","article-title":"Prospective randomized trial to assess effects of continuing hormone therapy on cerebral function in postmenopausal women at risk for dementia","volume":"9","author":"Rasgon","year":"2014","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1002\/14651858.CD004143.pub7-BIB0226|cit226","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1161\/hq0901.095565","article-title":"Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vaso-dilation in postmenopausal women","volume":"21","author":"Saitta","year":"2001","journal-title":"Arteriosclerosis, Thrombosis and Vascular Biology"},{"issue":"9","key":"10.1002\/14651858.CD004143.pub7-BIB0227|cit227","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1002\/art.22855","article-title":"Menopause hormonal therapy in women with systemic lupus erythematosus","volume":"56","author":"Sanchez-Guerrero","year":"2007","journal-title":"Arthritis and Rheumatism"},{"issue":"e6409","key":"10.1002\/14651858.CD004143.pub7-BIB0228|cit228","first-page":"1","article-title":"Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial","volume":"345","author":"Scheirbeck","year":"2012","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0229|cit229","unstructured":"A double-blind, randomized, placebo-and active-controlled efficacy and safety study of the effects of bazedoxifene\/conjugated estrogens combinations on endometrial hyperplasia and prevention of osteoporosis in postmenopausal women: SMART 5 https:\/\/clinicaltrials.gov\/study\/NCT00808132"},{"issue":"2","key":"10.1002\/14651858.CD004143.pub7-BIB0230|cit230","doi-asserted-by":"publisher","first-page":"E189","DOI":"10.1210\/jc.2013-1707","article-title":"Effects of bazedoxifene\/conjugated estrogens on the endometrium and bone: a randomized trial","volume":"99","author":"Pinkerton","year":"2014","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0231|cit231","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/01.AOG.0000251518.56369.eb","article-title":"Unopposed estradiol therapy in postmenopausal women","volume":"109","author":"Steiner","year":"2007","journal-title":"Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD004143.pub7-BIB0232|cit232","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1080\/13697137.2022.2158728","article-title":"Effect of hormone replacement therapy on intervertebral disc height","volume":"26","author":"Stevenson","year":"2023","journal-title":"Climacteric"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0233|cit233","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/cmt.5.2.160.169","article-title":"Placebo-controlled trial of transdermal estrogen therapy alone in postmenopausal women: effects on arterial compliance and endothelial function","volume":"5","author":"Teede","year":"2002","journal-title":"Climacteric"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0234|cit234","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/01.gme.0000192439.82491.24","article-title":"Effects of ultralow-dose transdermal estradiol on postmenopausal symptoms in women aged 60 to 80 years","volume":"1","author":"Diem","year":"2006","journal-title":"Menopause (New York, N.Y.)"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0235|cit235","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1097\/01.AOG.0000182576.48290.6d","article-title":"The effect of ultralow-dose transdermal estradiol on urinary incontinence in postmenopausal women","volume":"1","author":"Waetjen","year":"2005","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0236|cit236","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1471-0528.1999.tb08216.x","article-title":"Climacteric vasomotor symptoms do not imply autonomic dysfunction","volume":"106","author":"Virtanen","year":"1999","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0237|cit237","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3233\/JAD-2011-110341","article-title":"Short-term hormone therapy with transdermal estradiol improves cognition for postmenopausal women with Alzheimer's disease: results of a randomized controlled trial","volume":"26","author":"Wharton","year":"2011","journal-title":"Journal of Alzheimer's Disease"},{"issue":"8","key":"10.1002\/14651858.CD004143.pub7-BIB0238|cit238","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1097\/GME.0000000000001140","article-title":"Menopausal hormone therapy and mild cognitive impairment: a randomized, placebo-controlled trial","volume":"25","author":"Yoon","year":"2018","journal-title":"Menopause (New York, N.Y.)"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0239|cit239","unstructured":"Prevention and treatment of estrogen therapy on the perimenopausal diseases of multi-center study in China Chinese Clinical Trial Register"},{"issue":"6","key":"10.1002\/14651858.CD004143.pub7-BIB0240|cit240","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1056\/NEJMoa030830","article-title":"Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women","volume":"349","author":"Hodis","year":"2003","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0241|cit241","unstructured":"Estetrol for the treatment of moderate to severe vasomotor symptoms in postmenopausal women https:\/\/clinicaltrials.gov\/study\/NCT04090957"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0242|cit242","unstructured":"Estetrol for the treatment of moderate to severe vasomotor symptoms in postmenopausal women (e4comfort study I) Clinical trials.gov"},{"issue":"12","key":"10.1002\/14651858.CD004143.pub7-BIB0243|cit243","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1097\/GME.0000000000001456","article-title":"A phase 3 protocol to assess the efficacy and safety of estetrol (E4), a promising new treatment for menopausal vasomotor symptoms","volume":"26","author":"Utian","year":"2019","journal-title":"Menopause (New York, N.Y.)"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0244|cit244","unstructured":"Micronized progesterone versus norethisterone acetate in combination with estrogen as menopausal hormone therapy https:\/\/clinicaltrials.gov\/study\/NCT05586724"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0245|cit245","doi-asserted-by":"publisher","first-page":"e6409","DOI":"10.1136\/bmj.e6409","article-title":"Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial","volume":"345","author":"Abelin","year":"2012","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0246|cit246","unstructured":"Australian Menopause Society AMS guide to equivalent HRT\/MHT doses https:\/\/www.menopause.org.au\/for-women\/information-sheets\/426-ams-guide-to-equivalent-hrt-mht-doses"},{"issue":"13","key":"10.1002\/14651858.CD004143.pub7-BIB0247|cit247","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1001\/jama.290.13.1739","article-title":"Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures","volume":"290","author":"Anderson","year":"2003","journal-title":"JAMA"},{"issue":"14","key":"10.1002\/14651858.CD004143.pub7-BIB0248|cit248","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial","volume":"291","author":"Anderson","year":"2004","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0249|cit249","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.maturitas.2006.05.004","article-title":"Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin","volume":"55","author":"Anderson","year":"2006","journal-title":"Maturitas"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0250|cit250","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/S1470-2045(12)70075-X","article-title":"Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial","volume":"13","author":"Anderson","year":"2012","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD004143.pub7-BIB0251|cit251","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0277-9536(00)00147-7","article-title":"Is there a menopausal syndrome? Menopausal status and symptoms across racial\/ethnic groups","volume":"52","author":"Avis","year":"2001","journal-title":"Social Science & Medicine"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0252|cit252","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/aje\/kwp113","article-title":"Invited Commentary: Hormone therapy risks and benefits \u2013 The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis","volume":"1","author":"Banks","year":"2009","journal-title":"American Journal of Epidemiology"},{"issue":"11","key":"10.1002\/14651858.CD004143.pub7-BIB0253|cit253","doi-asserted-by":"publisher","first-page":"e1000181","DOI":"10.1371\/journal.pmed.1000181","article-title":"Hip fracture incidence in relation to age, menopausal status, and age at menopause: prospective analysis","volume":"6","author":"Banks","year":"2009","journal-title":"PLoS Medicine"},{"issue":"1","key":"10.1002\/14651858.CD004143.pub7-BIB0254|cit254","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1016\/s0020-7292(97)90196-x","article-title":"HRT and the risk of deep vein thrombosis","volume":"59","author":"Barlow","year":"1997","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"5","key":"10.1002\/14651858.CD004143.pub7-BIB0255|cit255","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/aje\/kwm214","article-title":"Hormones and heart disease: the timing hypothesis","volume":"166","author":"Barrett-Connor","year":"2007","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0256|cit256","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1146\/annurev.publhealth.19.1.55","article-title":"Hormone replacement therapy, heart disease and other considerations","volume":"19","author":"Barrett-Connor","year":"1998","journal-title":"Annual Review of Public Health"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0257|cit257","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/ije\/30.3.423","article-title":"Hormone replacement therapy (HRT) - risks and benefits","volume":"30","author":"Barrett-Connor","year":"2001","journal-title":"International Journal of Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD004143.pub7-BIB0258|cit258","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.metabol.2016.01.004","article-title":"The timing hypothesis: do coronary risks of menopausal hormone therapy vary by age or time since menopause onset?","volume":"65","author":"Bassuk","year":"2016","journal-title":"Metabolism: Clinical and Experimental"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0259|cit259","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/bmj.38331.655347.8F","article-title":"Association between hormone replacement therapy and subsequent stroke: a meta-analysis","volume":"330","author":"Bath","year":"2005","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0260|cit260","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0140-6736(02)11032-4","article-title":"Evidence from randomised trials on the long-term effects of hormone replacement therapy","volume":"360","author":"Beral","year":"2002","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0261|cit261","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14596-5","article-title":"Breast cancer and hormone-replacement therapy in the Million Women Study","volume":"362","author":"Beral","year":"2003","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0262|cit262","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1093\/jnci\/djq527","article-title":"Breast cancer risk in relation to the interval between menopause and starting hormone therapy","volume":"103","author":"Beral","year":"2011","journal-title":"Journal of the National Cancer Institute"},{"issue":"6","key":"10.1002\/14651858.CD004143.pub7-BIB0263|cit263","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1093\/aje\/kwx131","article-title":"Hormone therapy use and risk of chronic disease in the nurses' health study: a comparative analysis with the Women's Health Initiative","volume":"186","author":"Bhupathiraju","year":"2017","journal-title":"American Journal of Epidemiology"},{"issue":"3","key":"10.1002\/14651858.CD004143.pub7-BIB0264|cit264","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002229.pub4","article-title":"Hormone therapy for preventing cardiovascular disease in post-menopausal women","author":"Boardman","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD004143.pub7-BIB0265|cit265","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/CIRCULATIONAHA.106.642280","article-title":"Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study","volume":"115","author":"Canonico","year":"2007","journal-title":"Circulation"},{"issue":"13","key":"10.1002\/14651858.CD004143.pub7-BIB0266|cit266","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.290.13.1729","article-title":"Effects of estrogen plus progestin on risk of fracture and bone mineral density","volume":"290","author":"Cauley","year":"2003","journal-title":"JAMA"},{"issue":"10204","key":"10.1002\/14651858.CD004143.pub7-BIB0267|cit267","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/S0140-6736(19)31709-X","article-title":"Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence","volume":"394","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"2019","journal-title":"Lancet"},{"issue":"7","key":"10.1002\/14651858.CD004143.pub7-BIB0268|cit268","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.cjca.2013.08.006","article-title":"Mechanisms of estrogen effects on the endothelium: an overview","volume":"30","author":"Chakrabarti","year":"2014","journal-title":"Canadian Journal of Cardiology"},{"issue":"24","key":"10.1002\/14651858.CD004143.pub7-BIB0269|cit269","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1001\/jama.289.24.3243","article-title":"Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women","volume":"289","author":"Chlebowski","year":"2003","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0270|cit270","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0140-6736(04)15519-0","article-title":"Menopausal hormone therapy after breast cancer","volume":"363","author":"Chlebowski","year":"2004","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD004143.pub7-BIB0271|cit271","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/archinternmed.2007.123","article-title":"Estrogen plus progestin and breast cancer detection by means of mammography and breast biopsy","volume":"168","author":"Chlebowski","year":"2008","journal-title":"Archives of Internal Medicine"},{"issue":"9697","key":"10.1002\/14651858.CD004143.pub7-BIB0272|cit272","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0140-6736(09)61526-9","article-title":"Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial","volume":"374","author":"Chlebowski","year":"2009","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0273|cit273","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1200\/JCO.2009.24.8799","article-title":"Estrogen alone in postmenopausal women and breast cancer detection by means of mammography and breast biopsy","volume":"28","author":"Anderson","year":"2010","journal-title":"Journal of Clinical Oncology"},{"issue":"18","key":"10.1002\/14651858.CD004143.pub7-BIB0274|cit274","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/jnci\/djq285","article-title":"Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trial","volume":"102","author":"Chlebowski","year":"2010","journal-title":"Journal of the National Cancer Institute"},{"issue":"15","key":"10.1002\/14651858.CD004143.pub7-BIB0275|cit275","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1001\/jama.2010.1500","article-title":"Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women","volume":"304","author":"Chlebowski","year":"2010","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD004143.pub7-BIB0276|cit276","first-page":"296","article-title":"Breast cancer after use of estrogen plus progestin and estrogen alone","volume":"1","author":"Chlebowski","year":"2015","journal-title":"JAMA"},{"issue":"7","key":"10.1002\/14651858.CD004143.pub7-BIB0277|cit277","doi-asserted-by":"crossref","first-page":"917","DOI":"10.6004\/jnccn.2015.0106","article-title":"Menopausal hormone therapy influence on breast cancer outcomes in the Women's Health Initiative","volume":"13","author":"Chlebowski","year":"2015","journal-title":"Journal of the National Comprehensive Cancer Network"},{"issue":"4","key":"10.1002\/14651858.CD004143.pub7-BIB0278|cit278","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1001\/jama.2020.9482","article-title":"Association of menopausal hormone therapy with breast cancer incidence and mortality during long-term follow-up of the women's health initiative randomized clinical trials","volume":"24","author":"Chlebowski","year":"2020","journal-title":"JAMA"},{"issue":"10","key":"10.1002\/14651858.CD004143.pub7-BIB0279|cit279","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001405.pub3","article-title":"Oestrogen therapy for urinary incontinence in post-menopausal women","author":"Cody","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD004143.pub7-BIB0280|cit280","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001405.pub3","article-title":"Oestrogen therapy for urinary incontinence in post-menopausal women","author":"Cody","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"13","key":"10.1002\/14651858.CD004143.pub7-BIB0281|cit281","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1001\/jama.292.13.1573","article-title":"Estrogen plus progestin and risk of venous thrombosis","volume":"292","author":"Cushman","year":"2004","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD004143.pub7-BIB0282|cit282","doi-asserted-by":"publisher","first-page":"33","DOI":"10.18553\/jmcp.2004.10.1.33","article-title":"Clinical monograph: hormone replacement therapy","volume":"10","author":"Deady","year":"2004","journal-title":"Journal of Managed Care Specialty Pharmacy"},{"issue":"5","key":"10.1002\/14651858.CD004143.pub7-BIB0283|cit283","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1111\/j.1538-7836.2005.01268.x","article-title":"Does the type of hormone replacement therapy influence the risk of deep vein thrombosis? A prospective case-control study","volume":"3","author":"Douketis","year":"2005","journal-title":"Journal of Thrombosis and Haemostasis: JTH"},{"issue":"10","key":"10.1002\/14651858.CD004143.pub7-BIB0284|cit284","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/GME.0000000000001424","article-title":"The menopause transition and women\u2019s health at midlife: a progress report from the Study of Women\u2019s Health Across the Nation (SWAN)","volume":"26","author":"El Khoudary","year":"2019","journal-title":"Menopause (New York, N.Y.)"},{"issue":"24","key":"10.1002\/14651858.CD004143.pub7-BIB0285|cit285","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1001\/jama.291.24.2959","article-title":"Conjugated equine estrogens and global cognitive function in postmenopausal women","volume":"291","author":"Espeland","year":"2004","journal-title":"JAMA"},{"issue":"15","key":"10.1002\/14651858.CD004143.pub7-BIB0286|cit286","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1001\/jamainternmed.2013.7727","article-title":"Long term effects on cognitive function of postmenopausal hormone therapy prescribed to women aged 50-55 years","volume":"173","author":"Espeland","year":"2013","journal-title":"JAMA Internal Medicine"},{"issue":"00","key":"10.1002\/14651858.CD004143.pub7-BIB0287|cit287","first-page":"11","article-title":"Long-term effects on cognitive trajectories of postmenopausal hormone therapy in two age groups","volume":"00","author":"Espeland","year":"2016","journal-title":"Journals of Gerontology Series A-Biological Sciences and Medical Sciences"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0288|cit288","unstructured":"Food and Drug Administration (FDA) Center for Drug Evaluation and Research Guidance for industry: estrogen and estrogen\/progestin drug products to treat vasomotor symptoms and vulvar and vaginal atrophy symptoms \u2013 recommendations for clinical evaluation Available at http:\/\/www.fda.gov\/cder\/guidance\/5412dft.doc; January 2003 http:\/\/www.fda.gov\/cder\/guidance\/5412dft.doc"},{"issue":"8","key":"10.1002\/14651858.CD004143.pub7-BIB0289|cit289","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000402.pub4","article-title":"Hormone therapy in postmenopausal women and risk of endometrial hyperplasia","author":"Furness","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD004143.pub7-BIB0290|cit290","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010407.pub2","article-title":"Bioidentical hormones for women with vasomotor symptoms","author":"Gaudard","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7381","key":"10.1002\/14651858.CD004143.pub7-BIB0291|cit291","first-page":"126","article-title":"FDA insists that oestrogen products for menopause carry a warning","volume":"326","author":"Gottlieb","year":"2003","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"2","key":"10.1002\/14651858.CD004143.pub7-BIB0292|cit292","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/0029-7844(94)00383-O","article-title":"Hormone replacement therapy and endometrial cancer risk: a meta-analysis","volume":"85","author":"Grady","year":"1995","journal-title":"Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD004143.pub7-BIB0293|cit293","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1001\/jama.288.1.49","article-title":"Cardiovascular disease outcomes during 6.8 years of hormone therapy: heart and estrogen\/progestin replacement study follow-up (HERS II)","volume":"288","author":"Grady","year":"2002","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0294|cit294","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(98)05352-5","article-title":"The menopause","volume":"353","author":"Greendale","year":"1999","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD004143.pub7-BIB0295|cit295","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/humupd\/dmm012","article-title":"Menopausal hormone therapy and risk of ovarian cancer: systematic review and meta-analysis","volume":"13","author":"Greiser","year":"2007","journal-title":"Human Reproduction Update"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0296|cit296","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/(SICI)1097-0142(19990915)86:6<1013::AID-CNCR17>3.0.CO;2-1","article-title":"Estrogen replacement for ovarian cancer survivors: a randomized controlled trial","volume":"86","author":"Guidozzi","year":"1999","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0297|cit297","unstructured":"US Department of Health and Human Services Fact sheet: FDA initiates removal of \u201cblack box\u201d warnings from menopausal hormone replacement therapy products; November 2025 https:\/\/www.hhs.gov\/press-room\/fact-sheet-fda-initiates-removal-of-black-box-warnings-from-menopausal-hormone-replacement-therapy-products.html"},{"issue":"9","key":"10.1002\/14651858.CD004143.pub7-BIB0298|cit298","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1001\/jama.299.9.1036","article-title":"Health risks and benefit 3 years after stopping randomized treatment with estrogen and progestin","volume":"299","author":"Heiss","year":"2008","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0299|cit299","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/bmj.315.7101.149","article-title":"Impact of post menopausal hormone therapy on cardiovascular events and cancer: pooled data from clinical trials","volume":"315","author":"Hemminki","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0300|cit300","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/140349480002800201","article-title":"Hormone replacement therapy: discrepancies between evidence and recommendations","volume":"28","author":"Hemminki","year":"2000","journal-title":"Scandinavian Journal of Public Health"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0301|cit301","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0140-6736(99)03432-7","article-title":"Value of drug-licensing documents in studying the effect of postmenopausal hormone therapy on cardiovascular disease","volume":"355","author":"Hemminki","year":"2000","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0302|cit302","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1161\/CIRCULATIONAHA.105.594077","article-title":"Effects of conjugated equine estrogen on stroke in the Women's Health Initiative","volume":"113","author":"Hendrix","year":"2006","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0303|cit303","unstructured":"Higgins JP Altman DG Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017 Available from https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/archive\/v5.2.0"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0304|cit304","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from training.cochrane.org\/handbook"},{"issue":"1","key":"10.1002\/14651858.CD004143.pub7-BIB0305|cit305","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003799.pub2","article-title":"Hormone replacement therapy to maintain cognitive function in women with dementia","author":"Hogervorst","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0306|cit306","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(04)15493-7","article-title":"HABITS (hormonal replacement therapy after breast cancer \u2013 is it safe?), a randomised comparison: trial stopped","volume":"363","author":"Holmberg","year":"2004","journal-title":"Lancet"},{"issue":"7","key":"10.1002\/14651858.CD004143.pub7-BIB0307|cit307","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/jnci\/djn058","article-title":"Increased risk of recurrence after hormone replacement therapy in breast cancer survivors","volume":"100","author":"Holmberg","year":"2008","journal-title":"Journal of the National Cancer Institute"},{"issue":"280","key":"10.1002\/14651858.CD004143.pub7-BIB0308|cit308","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen\/progestin Replacement Study (HERS) Research Group","volume":"19","author":"Hulley","year":"1998","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD004143.pub7-BIB0309|cit309","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1001\/jama.288.1.58","article-title":"Noncardiovascular disease outcomes during 6.8 years of hormone replacement. Heart and Estrogen\/progestin Replacement Study follow-up (HERS II)","volume":"288","author":"Hulley","year":"2002","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0310|cit310","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1001\/jama.291.14.1769","article-title":"The WHI estrogen-alone trial - do things look any better?","volume":"291","author":"Hulley","year":"2004","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0311|cit311","unstructured":"Institute of Cancer Research UK randomised trial of hormone replacement therapy (HRT) in women with a history of early breast cancer http:\/\/www.icr.ac.uk\/ctsu\/hrt.htm"},{"issue":"9","key":"10.1002\/14651858.CD004143.pub7-BIB0312|cit312","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007063.pub2","article-title":"Oestrogens for treatment or prevention of pelvic organ prolapse in postmenopausal women","author":"Ismail","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD004143.pub7-BIB0313|cit313","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/ERC-14-0448","article-title":"The new biology of estrogen induced apoptosis applied to treat and prevent breast cancer","volume":"22","author":"Jordan","year":"2015","journal-title":"Endocrine-related Cancer"},{"issue":"10","key":"10.1002\/14651858.CD004143.pub7-BIB0314|cit314","first-page":"802","article-title":"Effect on blood pressure and other cardiovascular risk factors","volume":"30","author":"Kaplan","year":"1985","journal-title":"Journal of Reproductive Medicine"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0315|cit315","unstructured":"Kaunitz AM Use of combination hormone replacement therapy in light of recent data from the Women's Health Initiative Mayo Clinic Proceedings 2002 77 11 1243\u201351 10.4065\/77.11.1243"},{"issue":"10","key":"10.1002\/14651858.CD004143.pub7-BIB0316|cit316","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000402.pub5","article-title":"Hormone therapy in postmenopausal women and risk of endometrial hyperplasia or endometrial cancer","author":"Kim","year":"2025","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD004143.pub7-BIB0317|cit317","first-page":"23","article-title":"The effects of postmenopausal estrogen therapy on the incidence of arteriosclerotic vascular disease","volume":"72","author":"Knopp","year":"1988","journal-title":"Obstetrics and Gynaecology"},{"issue":"3","key":"10.1002\/14651858.CD004143.pub7-BIB0318|cit318","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.sxmr.2019.03.006","article-title":"The history of estrogen therapy","volume":"7","author":"Kohn","year":"2019","journal-title":"Sexual Medicine Reviews"},{"issue":"3","key":"10.1002\/14651858.CD004143.pub7-BIB0319|cit319","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001018","article-title":"Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution","author":"Kongnyuy","year":"1999","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD004143.pub7-BIB0320|cit320","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X","article-title":"Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma","volume":"56","author":"Kurman","year":"1985","journal-title":"Cancer"},{"issue":"13","key":"10.1002\/14651858.CD004143.pub7-BIB0321|cit321","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1001\/jama.2011.382","article-title":"Health outcomes after stopping conjugated equine esotrogens among postmenopausal women with prior hysterectomy","volume":"305","author":"LaCroix","year":"2011","journal-title":"JAMA"},{"issue":"8","key":"10.1002\/14651858.CD004143.pub7-BIB0322|cit322","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009672.pub3","article-title":"Hormone therapy for sexual function in perimenopausal and postmenopausal women","author":"Lara","year":"2023","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD004143.pub7-BIB0323|cit323","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003122.pub2","article-title":"Hormone replacement therapy for cognitive function in postmenopausal women","author":"Lethaby","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD004143.pub7-BIB0324|cit324","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001500.pub3","article-title":"Local oestrogen for vaginal atrophy in postmenopausal women","author":"Lethaby","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD004143.pub7-BIB0325|cit325","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002978.pub2","article-title":"Oral oestrogen and combined oestrogen\/progestogen therapy versus placebo for hot flushes","author":"MacLennan","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0326|cit326","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa030808","article-title":"Estrogen plus progestin and the risk of coronary heart disease","volume":"349","author":"Manson","year":"2003","journal-title":"New England Journal of Medicine"},{"issue":"13","key":"10.1002\/14651858.CD004143.pub7-BIB0327|cit327","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.2013.278040","article-title":"Menopausal hormone therapy and health outcomes during the intervention and extended post-stopping phases of the Women's Health Intiative randomized trials","volume":"310","author":"Manson","year":"2013","journal-title":"JAMA"},{"issue":"4","key":"10.1002\/14651858.CD004143.pub7-BIB0328|cit328","first-page":"437","article-title":"The \u2018timing hypothesis\u2019 for estrogen therapy in menopausal symptom management","volume":"11","author":"Manson","year":"2015","journal-title":"Women's Health (Hillsdale, N.J.)"},{"issue":"8","key":"10.1002\/14651858.CD004143.pub7-BIB0329|cit329","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1097\/GME.0000000000001553","article-title":"The Women's Health Initiative trials of menopausal hormone therapy: lessons learned","volume":"27","author":"Manson","year":"2020","journal-title":"Menopause (New York, N.Y.)"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0330|cit330","doi-asserted-by":"crossref","first-page":"e8141","DOI":"10.1136\/bmj.e8141","article-title":"Trial does not change the conclusions of Cochrane review of long term hormone therapy for perimenopausal and postmenopausal women","volume":"345","author":"Marjoribanks","year":"2012","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD004143.pub7-BIB0331|cit331","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1037\/0003-066X.52.2.101","article-title":"Women's Health Initiative: why now? What is it? What's new?","volume":"52","author":"Matthews","year":"1997","journal-title":"American Psychologist"},{"issue":"1","key":"10.1002\/14651858.CD004143.pub7-BIB0332|cit332","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2165\/00003495-199856010-00005","article-title":"A practical guide to prescribing hormone replacement therapy","volume":"56","author":"McKinney","year":"1998","journal-title":"Drugs"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0333|cit333","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1124\/pr.107.08002","article-title":"Vascular actions of estrogens: functional implications","volume":"60","author":"Miller","year":"2008","journal-title":"Pharmacological Reviews"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0334|cit334","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1002\/14651858.CD012658.pub2","article-title":"Levonorgestrel-releasing intrauterine system for endometrial hyperplasia","volume":"9","author":"Mittermeier","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0335|cit335","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0336|cit336","unstructured":"Mukherjee A Davis S Update on menopause hormone therapy; current indications and unanswered questions Clinical Endocrinology 10.1111\/cen.15211"},{"issue":"7","key":"10.1002\/14651858.CD004143.pub7-BIB0337|cit337","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1097\/GME.0000000000000921","article-title":"The 2017 Hormone Therapy Position Statement of the North American Menopause Society","volume":"24","author":"Hormone Therapy Position Statement Advisory Panel","year":"2017","journal-title":"Menopause (New York, N.Y.)"},{"issue":"7","key":"10.1002\/14651858.CD004143.pub7-BIB0338|cit338","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1097\/GME.0000000000002028","article-title":"The 2022 hormone therapy position statement of the North American Menopause Society","volume":"29","author":"North American Menopause Society (NAMS) Advisory Panel","year":"2022","journal-title":"Menopause (New York, N.Y.)"},{"issue":"6","key":"10.1002\/14651858.CD004143.pub7-BIB0339|cit339","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009672.pub2","article-title":"Hormone therapy for sexual function in perimenopausal and postmenopausal women","author":"Nastri","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD004143.pub7-BIB0340|cit340","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s00404-021-06380-5","article-title":"Endometrial hyperplasia as a risk factor of endometrial cancer","volume":"306","author":"Nees","year":"2022","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"9614","key":"10.1002\/14651858.CD004143.pub7-BIB0341|cit341","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0140-6736(08)60346-3","article-title":"Menopause","volume":"371","author":"Nelson","year":"2008","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0342|cit342","unstructured":"National Institute for Health and Care Excellence Menopause. Clinical Guideline: methods, evidence and recommendations; October 2015 https:\/\/www.nice.org.uk\/guidance\/ng23\/evidence\/full-guideline-559549261"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0343|cit343","unstructured":"National Institute for Health and Care Excellence Menopause: identification and management. NG23; November 2015; last updated November 2024 https:\/\/www.nice.org.uk\/guidance\/ng23\/chapter\/recommendations"},{"issue":"4","key":"10.1002\/14651858.CD004143.pub7-BIB0344|cit344","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/GME.0b013e31828865a5","article-title":"The scientific rationale for a delay after menopause in the use of conjugated equine estrogens in postmenopausal women that causes a reduction in breast cancer incidence and mortality","volume":"20","author":"Obiorah","year":"2013","journal-title":"Menopause (New York, N.Y.)"},{"issue":"2","key":"10.1002\/14651858.CD004143.pub7-BIB0345|cit345","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/humupd\/dmy039","article-title":"The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic review","volume":"25","author":"Oliver-Williams","year":"2019","journal-title":"Human Reproduction Update"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0346|cit346","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3109\/13697137.2010.507886","article-title":"Age of menopause and impact of climacteric symptoms by geographical region","volume":"13","author":"Palacios","year":"2010","journal-title":"Climacteric"},{"issue":"11","key":"10.1002\/14651858.CD004143.pub7-BIB0347|cit347","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1093\/humrep\/deg435","article-title":"Issues to debate on the Women's Health Initiative (WHI) study. Epidemiology or randomized clinical trials - time out for hormone replacement therapy studies?","volume":"18","author":"Pedersen","year":"2003","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0348|cit348","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/aje\/kwp115","article-title":"Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause","volume":"170","author":"Prentice","year":"2009","journal-title":"American Journal of Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD004143.pub7-BIB0349|cit349","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1158\/1055-9965.EPI-08-1209","article-title":"Colorectal cancer in relation to postmenopausal estrogen and estrogen plus progestin in the Women's Health Initiative clinical trial and observational study","volume":"18","author":"Prentice","year":"2009","journal-title":"Cancer Epidemiology, Biomarkers and Prevention"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0350|cit350","unstructured":"Royal Australian and New Zealand College of Obstetricians and Gynaecologists Managing menopausal symptoms; September 2020 Available at https:\/\/ranzcog.edu.au\/wp-content\/uploads\/2022\/05\/Managing-menopausal-symptoms.pdf 2020 https:\/\/ranzcog.edu.au\/wp-content\/uploads\/2022\/05\/Managing-menopausal-symptoms.pdf"},{"issue":"1","key":"10.1002\/14651858.CD004143.pub7-BIB0351|cit351","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/157488712799363253","article-title":"Vascular effects of estrogenic menopausal hormone therapy","volume":"7","author":"Reslan","year":"2012","journal-title":"Review of Recent Clinical Trials"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0352|cit352","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1191\/1740774504cn040oa","article-title":"The Women's Health Initiative Study of Cognitive Aging (WHISCA): a randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline","volume":"1","author":"Resnick","year":"2004","journal-title":"Clinical Trials (London, England)"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0353|cit353","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2025"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0354|cit354","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1525-1497.2004.30281.x","article-title":"Mortality associated with hormone replacement therapy in younger and older women","volume":"19","author":"Salpeter","year":"2004","journal-title":"Journal of General Internal Medicine"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0355|cit355","doi-asserted-by":"publisher","first-page":"Art. No.: CD011","DOI":"10.1002\/14651858.CD011066.pub2","article-title":"Dehydroepiandrosterone for women in the peri- or postmenopausal phase","volume":"1","author":"Scheffers","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0356|cit356","doi-asserted-by":"crossref","first-page":"e6409","DOI":"10.1136\/bmj.e6409","article-title":"Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial","volume":"345","author":"Schroll","year":"2012","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0357|cit357","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence [last updated August 2023]. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available from cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0358|cit358","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1080\/cmt.6.4.302.313","article-title":"Risks of estrogen plus progestin therapy: a sensitivity analysis of findings in the Women's Health Initiative randomized controlled trial","volume":"6","author":"Shapiro","year":"2003","journal-title":"Climacteric"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0359|cit359","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S0197-2456(98)00038-5","article-title":"The Women's Health Initiative Memory Study (WHIMS): a trial of the effect of estrogen therapy in preventing and slowing the progression of dementia","volume":"19","author":"Shumaker","year":"1998","journal-title":"Controlled Clinical Trials"},{"issue":"20","key":"10.1002\/14651858.CD004143.pub7-BIB0360|cit360","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1001\/jama.289.20.2651","article-title":"Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial","volume":"289","author":"Shumaker","year":"2004","journal-title":"JAMA"},{"issue":"24","key":"10.1002\/14651858.CD004143.pub7-BIB0361|cit361","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.291.24.2947","article-title":"Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study","volume":"291","author":"Shumaker","year":"2004","journal-title":"JAMA"},{"issue":"32","key":"10.1002\/14651858.CD004143.pub7-BIB0362|cit362","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1200\/JCO.2012.42.7732","article-title":"Estrogen plus progestin and colorectal cancer incidence and mortality","volume":"30","author":"Simon","year":"2012","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1002\/14651858.CD004143.pub7-BIB0363|cit363","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/AOG.0b013e318265df42","article-title":"A sustained decline in postmenopausal hormone use: results from the National Health and Nutrition Examination Survey, 1999-2010","volume":"120","author":"Sprague","year":"2012","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0364|cit364","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/S1047-2797(03)00045-0","article-title":"The Women's Health Initiative postmenopausal hormone trials: overview and baseline characteristics of participants","volume":"13","author":"Stefanick","year":"2003","journal-title":"Annals of Epidemiology"},{"issue":"12 Suppl 2","key":"10.1002\/14651858.CD004143.pub7-BIB0365|cit365","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.amjmed.2005.09.059","article-title":"Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration","volume":"118","author":"Stefanick","year":"2005","journal-title":"American Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD004143.pub7-BIB0366|cit366","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001500.pub2","article-title":"Local oestrogen for vaginal atrophy in postmenopausal women","author":"Suckling","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD004143.pub7-BIB0367|cit367","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1097\/00042192","article-title":"Estrogen replacement therapy and gallbladder disease in postmenopausal women","volume":"7","author":"Uhler","year":"2000","journal-title":"Menopause (New York, N.Y.)"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0368|cit368","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.brainres.2013.03.047","article-title":"The rationale, design, and baseline characteristics of the Women's Health Initiative Memory Study of Younger Women (WHIMS-Y)","volume":"1514","author":"Vaughan","year":"2013","journal-title":"Brain Research"},{"issue":"1","key":"10.1002\/14651858.CD004143.pub7-BIB0369|cit369","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/s0197-2456(97)00078-0","article-title":"Design of the Women\u2019s Health Initiative clinical trial and observational study","volume":"19","author":"The Women\u2019s Health Initiative Study Group","year":"1998","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0370|cit370","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomised controlled trial","volume":"288","author":"Writing Group for the Women's Health Initiative Investigators","year":"2002","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD004143.pub7-BIB0371|cit371","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1097\/GME.0000000000002176","article-title":"Effects of menopausal hormone therapy on the risk of ovarian cancer: Health Insurance Database in South Korea\u2013based cohort study","volume":"30","author":"Yuk","year":"2023","journal-title":"Menopause (New York, N.Y.)"},{"key":"10.1002\/14651858.CD004143.pub7-BIB0372|cit372","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/bcr3632","article-title":"Sex hormone associations with breast cancer risk and the mediation of randomized trial postmenopausal hormone therapy effects","volume":"16","author":"Zhao","year":"2014","journal-title":"Breast Cancer Research"},{"issue":"4","key":"10.1002\/14651858.CD004143.pub7-BIB0373|cit373","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004143","article-title":"Hormone replacement therapy for perimenopausal and postmenopausal women","author":"Cochrane HRT Study Group","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD004143.pub7-BIB0374|cit374","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004143.pub2","article-title":"Long term hormone therapy for perimenopausal and postmenopausal women","author":"Farquhar","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD004143.pub7-BIB0375|cit375","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004143.pub3","article-title":"Long term hormone therapy for perimenopausal and postmenopausal women","author":"Farquhar","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD004143.pub7-BIB0376|cit376","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004143.pub4","article-title":"Long term hormone therapy for perimenopausal and postmenopausal women","author":"Marjoribanks","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD004143.pub7-BIB0377|cit377","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004143.pub5","article-title":"Long-term hormone therapy for perimenopausal and postmenopausal women","author":"Marjoribanks","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:35:38Z","timestamp":1789025738000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD004143.pub7"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":383,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004143.pub7","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]}}}